{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-24-000035","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.568769+00:00","generated_at":"2026-05-31T20:12:52.432109+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Intensity Therapeutics stockholders approve ESPP and re-elect directors at annual meeting","bullets":["8,522,632 shares represented (~62.15% quorum) at July 17, 2024 annual meeting.","Daniel Donovan and Thomas I.H. Dubin re-elected as Class I directors until 2027.","Stockholders approved 2024 Employee Stock Purchase Plan (ESPP) with 6.6M for, 103k against.","EisnerAmper LLP ratified as independent auditor for fiscal year ending December 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-24-000035","json":"https://secwatch.observer/filing/0001567264-24-000035.json","markdown":"https://secwatch.observer/filing/0001567264-24-000035.md","text":"https://secwatch.observer/filing/0001567264-24-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/0001567264-24-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/intensity-20240717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:12:52.432109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}